ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Cardiovascular health is evolving as an important consideration in patients with CML, not only because of the improved prognosis being enjoyed by patients treated with TKI-based therapies, but also because some later-generation BCR::ABL1 TKIs have been associated with cardiovascular complications [27].